You just read:

Soligenix Announces Publication of its Phase 2 Clinical Trial Results of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients

News provided by

Soligenix, Inc.

Oct 18, 2016, 07:00 ET